123 Main Street, New York, NY 10001

Top Navigation with Mega Menu
Investor Relations

This section of the Co-Diagnostics InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Co-Diagnosticsassumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQCODX
Beta(0.68)
Shares Outstanding30.6M
Average Volume (10 days)41.9K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.39)
Sales (TTM)$1.12
Book Value (MRQ)$3.25
Cash Flow (TTM)($0.70)
Cash (MRQ)$2.16

Analyst Views

Current Mean RecommendationHold
Strong Buy0
 
Buy0
 
Hold1
 
Underperform0
 
Sell0
 

Recent Insider Transactions

James B. Nelson
Director
30,000
Acquire
Nov 23, 2023
Durenard Eugene
Director
30,000
Acquire
Nov 23, 2023
Brian Lee Brown
Chief Financial Officer
118,332
Acquire
Nov 23, 2023
Dwight Egan
Chief Executive Officer
150,834
Acquire
Nov 23, 2023
James B. Nelson
Chairman
30,000
Acquire
Nov 23, 2023

Recent SEC Filings

Amended >= 5% Acquisition
Feb 13, 2024
Insider Buy/Sell
Nov 27, 2023
Insider Buy/Sell
Nov 27, 2023
Insider Buy/Sell
Nov 27, 2023
Insider Buy/Sell
Nov 27, 2023

Join Our Newsletter

Receive our latest blog posts directly in your inbox!